• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MMSET I 作为一种癌蛋白,调节 t(4;14)多发性骨髓瘤细胞中的 GLO1 表达。

MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cells.

机构信息

Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.

出版信息

Leukemia. 2019 Mar;33(3):739-748. doi: 10.1038/s41375-018-0300-0. Epub 2018 Nov 23.

DOI:10.1038/s41375-018-0300-0
PMID:30470837
Abstract

Multiple myeloma (MM) is characterized by recurrent chromosomal translocations. T(4;14) MM overexpresses multiple myeloma SET domain-containing protein (MMSET). MMSET has three major isoforms: the full-length form MMSET II and the short isoforms REIIBP and MMSET I. Here we show that the short isoform MMSET I is an oncoprotein that promoted cell survival and tumorigenesis in vitro and in vivo. Gene expression array analysis indicated that MMSET I increased glyoxalase I (GLO1) expression. Chromatin immunoprecipitation (ChIP) coupled with qPCR indicated that MMSET I bound upstream of the GLO1 transcription start site. Ectopic overexpression of MMSET I or its mutants showed MMSET I depended on its C terminus to regulate GLO1 expression. GLO1 knockdown (KD) induced apoptosis and reduced colony formation. MMSET I or GLO1 KD reduced the levels of anti-apoptosis factors such as MCL1 and BCL2. Ectopic overexpression of GLO1 resulted in the significant rescue of KMS11 cells from MMSET I KD-induced apoptosis and glycolysis inhibition. This suggested that GLO1 may be of functional importance target downstream of MMSET I. Cumulatively, our study suggests that MMSET I is an oncoprotein and potential therapeutic target for t(4;14) MM.

摘要

多发性骨髓瘤(MM)的特征是反复出现的染色体易位。T(4;14)MM 过表达多发性骨髓瘤 SET 域蛋白(MMSET)。MMSET 有三种主要的亚型:全长形式的 MMSET II 和短亚型 REIIBP 和 MMSET I。在这里,我们表明短亚型 MMSET I 是一种癌蛋白,它在体外和体内促进细胞存活和肿瘤发生。基因表达谱分析表明,MMSET I 增加了甘油醛-3-磷酸脱氢酶(GLO1)的表达。染色质免疫沉淀(ChIP)与 qPCR 表明 MMSET I 结合在 GLO1 转录起始位点的上游。过表达 MMSET I 或其突变体表明,MMSET I 依赖其 C 末端来调节 GLO1 的表达。GLO1 的敲低(KD)诱导细胞凋亡并减少集落形成。MMSET I 或 GLO1 KD 降低了抗凋亡因子如 MCL1 和 BCL2 的水平。过表达 GLO1 导致 KMS11 细胞从 MMSET I KD 诱导的细胞凋亡和糖酵解抑制中显著恢复。这表明 GLO1 可能是 MMSET I 下游的功能重要靶标。总之,我们的研究表明,MMSET I 是一种癌蛋白,是 t(4;14)MM 的潜在治疗靶点。

相似文献

1
MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cells.MMSET I 作为一种癌蛋白,调节 t(4;14)多发性骨髓瘤细胞中的 GLO1 表达。
Leukemia. 2019 Mar;33(3):739-748. doi: 10.1038/s41375-018-0300-0. Epub 2018 Nov 23.
2
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.MMSET 组蛋白甲基转移酶在 t(4;14)多发性骨髓瘤细胞中切换全局组蛋白甲基化并改变基因表达。
Blood. 2011 Jan 6;117(1):211-20. doi: 10.1182/blood-2010-07-298349. Epub 2010 Oct 25.
3
The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.与多发性骨髓瘤相关的MMSET基因有助于细胞黏附、克隆生长和致瘤性。
Blood. 2008 Jan 15;111(2):856-64. doi: 10.1182/blood-2007-05-088674. Epub 2007 Oct 17.
4
Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients.源自MMSET基因座的转录本过表达是所有t(4;14)(p16;q32)阳性多发性骨髓瘤患者的特征。
Blood. 2005 May 15;105(10):4060-9. doi: 10.1182/blood-2004-09-3704. Epub 2005 Jan 27.
5
Plasma membrane proteomics identifies biomarkers associated with MMSET overexpression in T(4;14) multiple myeloma.质膜蛋白质组学鉴定出与T(4;14)多发性骨髓瘤中MMSET过表达相关的生物标志物。
Oncotarget. 2013 Jul;4(7):1008-18. doi: 10.18632/oncotarget.1049.
6
The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.骨髓瘤中的t(4;14)易位使成纤维细胞生长因子受体3(FGFR3)和一个新基因MMSET均失调,从而产生免疫球蛋白重链(IgH)/MMSET融合转录本。
Blood. 1998 Nov 1;92(9):3025-34.
7
MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomib.MMSET 调节 t(4;14)骨髓瘤中 IRF4 的表达,其沉默增强硼替佐米的疗效。
Leukemia. 2015 Dec;29(12):2347-54. doi: 10.1038/leu.2015.169. Epub 2015 Jun 30.
8
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myeloma.转录抑制活性与多发性骨髓瘤中涉及t(4;14)的MMSET基因的I型异构体相关。
Br J Haematol. 2005 Oct;131(2):214-8. doi: 10.1111/j.1365-2141.2005.05741.x.
9
Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.联合荧光原位杂交(FISH)和DNA微阵列分析对多发性骨髓瘤癌基因失调的特征分析
Genes Chromosomes Cancer. 2005 Feb;42(2):117-27. doi: 10.1002/gcc.20123.
10
MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.MMSET失调影响t(4;14) 骨髓瘤浆细胞的细胞周期进程和黏附调节子。
Haematologica. 2009 Jan;94(1):78-86. doi: 10.3324/haematol.13426. Epub 2008 Dec 4.

引用本文的文献

1
Mitochondrial metabolic determinants of multiple myeloma growth, survival, and therapy efficacy.多发性骨髓瘤生长、存活及治疗疗效的线粒体代谢决定因素
Front Oncol. 2022 Sep 16;12:1000106. doi: 10.3389/fonc.2022.1000106. eCollection 2022.
2
Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach.抑制蛋白精氨酸甲基转移酶PRMT5作为高危多发性骨髓瘤的一种新型治疗方法
Front Cell Dev Biol. 2022 Jun 8;10:879057. doi: 10.3389/fcell.2022.879057. eCollection 2022.
3
NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein.

本文引用的文献

1
Mammalian Systems Biotechnology Reveals Global Cellular Adaptations in a Recombinant CHO Cell Line.哺乳动物系统生物技术揭示了重组 CHO 细胞系中的全局细胞适应性。
Cell Syst. 2017 May 24;4(5):530-542.e6. doi: 10.1016/j.cels.2017.04.009.
2
Multiple roles of glyoxalase 1-mediated suppression of methylglyoxal glycation in cancer biology-Involvement in tumour suppression, tumour growth, multidrug resistance and target for chemotherapy.糖氧还蛋白 1 介导的甲基乙二醛糖基化抑制在癌症生物学中的多重作用-在肿瘤抑制、肿瘤生长、多药耐药性和化疗靶点中的作用。
Semin Cancer Biol. 2018 Apr;49:83-93. doi: 10.1016/j.semcancer.2017.05.006. Epub 2017 May 12.
3
NSD2 通过甲基化和激活 STAT3 蛋白促进肿瘤血管生成。
Oncogene. 2021 Apr;40(16):2952-2967. doi: 10.1038/s41388-021-01747-z. Epub 2021 Mar 19.
4
Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma.靶向 NSD2 介导的 SRC-3 液-液相分离可增强多发性骨髓瘤对硼替佐米的治疗敏感性。
Nat Commun. 2021 Feb 15;12(1):1022. doi: 10.1038/s41467-021-21386-y.
5
Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma.多发性骨髓瘤中复发性基因畸变的代谢效应
Cancers (Basel). 2021 Jan 21;13(3):396. doi: 10.3390/cancers13030396.
6
WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling.WHSC1通过激活mTORC1信号促进肝癌细胞的增殖、迁移和侵袭。
Onco Targets Ther. 2020 Jul 20;13:7033-7044. doi: 10.2147/OTT.S248570. eCollection 2020.
7
The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context-Dependent Manner in Pediatric Acute Lymphoblastic Leukemia.NSD2 p.E1099K突变在复发时富集,并在儿童急性淋巴细胞白血病中以细胞背景依赖的方式赋予耐药性。
Mol Cancer Res. 2020 Aug;18(8):1153-1165. doi: 10.1158/1541-7786.MCR-20-0092. Epub 2020 Apr 24.
8
Molecular basis of clonal evolution in multiple myeloma.多发性骨髓瘤克隆进化的分子基础。
Int J Hematol. 2020 Apr;111(4):496-511. doi: 10.1007/s12185-020-02829-6. Epub 2020 Feb 6.
Structure of the Epigenetic Oncogene MMSET and Inhibition by N-Alkyl Sinefungin Derivatives.
表观遗传癌基因MMSET的结构及N-烷基杀稻瘟菌素衍生物的抑制作用
ACS Chem Biol. 2016 Nov 18;11(11):3093-3105. doi: 10.1021/acschembio.6b00308. Epub 2016 Sep 27.
4
Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes.组蛋白甲基转移酶NSD2对代谢进行重编程,通过磷酸戊糖途径酶的协同激活驱动内分泌抵抗。
Cancer Lett. 2016 Aug 10;378(2):69-79. doi: 10.1016/j.canlet.2016.05.004. Epub 2016 May 6.
5
Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2.甲基乙二醛和乙二醛酶I抑制通过调节丝裂原活化蛋白激酶、基质金属蛋白酶9和Bcl-2对乳腺癌细胞增殖、侵袭和凋亡的影响。
Cancer Biol Ther. 2016;17(2):169-80. doi: 10.1080/15384047.2015.1121346. Epub 2015 Nov 30.
6
CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.CD44变体6与晚期上皮性卵巢癌患者的腹膜播散及不良预后相关。
Cancer Sci. 2015 Oct;106(10):1421-8. doi: 10.1111/cas.12765. Epub 2015 Sep 21.
7
MB4-2 breakpoint in MMSET combined with del(17p) defines a subset of t(4;14) multiple myeloma with very poor prognosis.MMSET基因中的MB4-2断点与17p缺失相结合,定义了一组预后极差的t(4;14)多发性骨髓瘤。
Haematologica. 2015 Nov;100(11):e471-4. doi: 10.3324/haematol.2015.127001. Epub 2015 Jul 23.
8
MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomib.MMSET 调节 t(4;14)骨髓瘤中 IRF4 的表达,其沉默增强硼替佐米的疗效。
Leukemia. 2015 Dec;29(12):2347-54. doi: 10.1038/leu.2015.169. Epub 2015 Jun 30.
9
Inhibition of Nuclear Receptor Binding SET Domain 2/Multiple Myeloma SET Domain by LEM-06 Implication for Epigenetic Cancer Therapies.LEM-06对核受体结合SET结构域2/多发性骨髓瘤SET结构域的抑制作用对表观遗传癌症治疗的意义
J Cancer Prev. 2015 Jun;20(2):113-20. doi: 10.15430/JCP.2015.20.2.113.
10
Identification of recurrent regulated alternative splicing events across human solid tumors.人类实体瘤中复发性调控可变剪接事件的鉴定
Nucleic Acids Res. 2015 May 26;43(10):5130-44. doi: 10.1093/nar/gkv210. Epub 2015 Apr 23.